Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.

PUBLICATIONS

400+

LATEST PUBLICATIONS

Oncolytic Viruses Engineered to Enforce Leptin Expression Reprogram Tumor-Infiltrating T Cell Metabolism and Promote Tumor Clearance

Rivadeneira et al.

  • Immunity
  • September 2019

A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor- induced encephalitis

Johnson et al.

  • Nature Medicine
  • July 2019

Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity

Kuehm et al.

  • Cancer Immunology and Immunotherapy
  • May 2019

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Voorwerk et al.

  • Nature Medicine
  • May 2019

Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

Miller et al.

  • Nature Immunology
  • March 2019

Radiotherapy induces responses of lung cancer to CTLA-4 blockade

Formenti et al.

  • Nature Medicine
  • December 2018

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

Erhart et al.

  • Acta Neuropathologica
  • December 2018

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Blank et al.

  • Nature Medicine
  • November 2018

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

Naing et al.

  • Cancer Cell
  • November 2018
back_to_top